‘Breakthrough’: WHO hails steroid treatment for coronavirus
Al JazeeraUK study shows dexamethasone reduces deaths by about 30 percent in critical COVID patients, some US doctors sceptical. The World Health Organization plans to update its guidelines on treating people stricken with coronavirus to reflect results of a clinical trial that showed a cheap, common steroid could help save critically ill patients. ‘Best piece of news’ Britain’s health minister on Wednesday hailed the use of the steroid for treating coronavirus patients as the “best news” so far during the outbreak. “I just wait to see the real data, see if it’s peer-reviewed and gets published.” University of Washington professor of medicine Dr Mark Wurfel urged the researchers to release the data before official publication. “That would be very, very helpful in terms of helping us align our patient populations with theirs and decide whether it’s appropriate to apply this therapy to our patients,” said Wurfel.